US20240148781A1

Rhamnan sulfate-based therapeutics for nonalcoholic fatty liver disease and …

University of Texas System

Abstract

The present invention describes compositions and methods for treatment of metabolic diseases and disorders, such as non-alcoholic fatty liver disease (NAFLD), and circadian rhythm-related disorders.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Aaron Baker
Priority date: November 04, 2022
Filing date: November 03, 2023
Publication date: May 09, 2024
Language: en
PDF source: https://patentimages.storage.googleapis.com/96/bd/5b/ff9005a28c1703/US20240148781A1.pdf
Metadata fetched: August 29, 2026 00:32